CPIX - Company ID 0001087294
The table below shows CUMBERLAND PHARMACEUTICALS INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $387.02K | $3.90M | -$2.14M | -$1.42M | -$150.50K | $1.79M |
| Capital expenditure | $0.00 | $47.63K | $41.62K | $107.26K | $26.99K | $19.46K |
| Investing cash flow | -$61.17K | -$1.23M | -$58.19K | -$174.45K | -$13.54M | -$318.34K |
| Dividends paid | - | - | - |
CUMBERLAND PHARMACEUTICALS INC reported operating cash flow of $4.93M for fiscal year 2025. That is up 905.7% from -$612.19K in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $569.48K (FY 2016) to $4.93M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | $61.00K | $245.87K | $247.60K | $187.12K | $580.13K | $302.80K |
| Financing cash flow | -$763.30K | -$5.53M | $2.42M | -$1.78M | $3.92M | -$1.30M |